Axmed has raised $2 million to address supply chain fragmentation in underserved markets and streamline drug supply chains. The startup aims to link manufacturers with health institutions, aggregating demand to enable lower costs and reduce the proliferation of counterfeit drugs. Their initial target markets include Kenya, Nigeria, Ethiopia, Tanzania, and Rwanda. Axmed plans to create a sustainable marketplace that empowers buyers and patients and attracts high-quality manufacturers to these markets.
Sort: